“Global Agriculture Biologicals Testing Market to reach a market value of USD 4.3 Billion by 2030 growing at a CAGR of 6.9%”
The Global Agriculture Biologicals Testing Market size is expected to reach $4.3 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period.
North America has significantly shifted toward sustainable and environmentally friendly agricultural practices. Therefore, the North America region captured $901.41 million revenue in the market in 2022. Integrated Pest Management practices, which emphasize a holistic and sustainable approach to pest control, are gaining traction in North America. The organic farming sector in North America has experienced substantial growth, driven by consumer preferences for organic produce.
Sustainable soil health management emphasizes maintaining a diverse and balanced soil microbiome. Agriculture biologicals testing includes validating the impact of biofertilizers and biostimulants on soil microbial diversity. Testing ensures that biological inputs support a healthy and resilient soil ecosystem, promoting sustainable farming practices. Therefore, the market is expanding significantly due to the growing focus on sustainable soil health management.
Additionally, IPM promotes using biopesticides derived from natural sources such as beneficial microorganisms, botanical extracts, and insect pheromones. This verifies the effectiveness of biopesticides, ensuring they can be seamlessly integrated into IPM programs for targeted pest control without adverse effects on non-target organisms or the environment. Thus, because of the rising adoption of IPM, the market is anticipated to increase significantly.
However, negotiating through a complex regulatory landscape often leads to prolonged approval timelines for agriculture biologicals. The time taken to fulfill regulatory requirements, submit necessary documentation, and obtain approvals can significantly delay the introduction of new products to the market. Thus, complex regulatory landscape can slow down the growth of the market.
By product type, the market is categorized into biopesticides, biofertilizers, and biostimulants. In 2022, the biopesticides segment held 57.8% revenue share in the market. Biopesticides play a crucial role in integrated pest management (IPM) strategies, which focus on sustainable and multifaceted approaches to pest control. This verifies the compatibility of biopesticides with IPM practices, ensuring that these natural control agents can be seamlessly integrated into broader pest management strategies for optimal efficacy.
Based on end-user, the market is classified into government agencies, plant breeders, outsourced contract research organization, and biological product manufacturers. The government agencies segment acquired 24.3% revenue share in the market in 2022. Government agencies often allocate funds for research and development initiatives to advance agricultural technologies, including biologicals. This financial support contributes to the development of new and improved biological products.
Free Valuable Insights: Global Agriculture Biologicals Testing Market size to reach USD 4.3 Billion by 2030
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 27.7% revenue share in the market. An increasing number of Asia-Pacific countries are experiencing a surge in demand for environmentally favourable and sustainable agricultural practices. The population of the Asia-Pacific region is expanding quickly, raising worries about food security.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 2.5 Billion |
| Market size forecast in 2030 | USD 4.3 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 6.9% from 2023 to 2030 |
| Number of Pages | 188 |
| Number of Tables | 270 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product Type, End-User, Region |
| Country scope |
|
| Companies Included | LAUS GmbH, Eurofins Scientific SE, R J Hill Laboratories Limited, ALS Group, Société Générale de Surveillance SA. (SGS SA), Bionema Group Limited, Anadiag Group, SynTech Research Group, Lallemand Inc., The Mosaic Company |
By End-User
By Product Type
By Geography
This Market size is expected to reach $4.3 billion by 2030.
Growing focus on sustainable soil health management are driving the Market in coming years, however, Adverse impact of complex regulatory landscape restraints the growth of the Market.
LAUS GmbH, Eurofins Scientific SE, R J Hill Laboratories Limited, ALS Group, Société Générale de Surveillance SA. (SGS SA), Bionema Group Limited, Anadiag Group, SynTech Research Group, Lallemand Inc., The Mosaic Company
The expected CAGR of this Market is 6.9% from 2023 to 2030.
The Biological Product Manufacturers segment is generating highest revenue in the Market, by End-User in 2022; there by, achieving a market value of $1.8 Billion by 2030.
The North America region dominated the Market, by Region in 2022, and would continue to be a dominant market till 2030; there by, achieving a market value of $1.5 Billion by 2030.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 